Hohmann AG - Search Results

1

The cannabinoid CB₂ receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence.

Iyer V, Slivicki RA, Thomaz AC, Crystal JD, Mackie K, Hohmann AG. Iyer V, et al. Among authors: hohmann ag. Eur J Pharmacol. 2020 Nov 5;886:173544. doi: 10.1016/j.ejphar.2020.173544. Epub 2020 Sep 5. Eur J Pharmacol. 2020. PMID: 32896549 Free PMC article.

2

Cannabinoid modulation of sensitivity to time.

Crystal JD, Maxwell KW, Hohmann AG. Crystal JD, et al. Among authors: hohmann ag. Behav Brain Res. 2003 Sep 15;144(1-2):57-66. doi: 10.1016/s0166-4328(03)00062-7. Behav Brain Res. 2003. PMID: 12946595

3

Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin.

Hohmann AG, Farthing JN, Zvonok AM, Makriyannis A. Hohmann AG, et al. J Pharmacol Exp Ther. 2004 Feb;308(2):446-53. doi: 10.1124/jpet.103.060079. Epub 2003 Nov 10. J Pharmacol Exp Ther. 2004. PMID: 14610224

4

An endocannabinoid mechanism for stress-induced analgesia.

Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, Krey JF, Walker JM, Holmes PV, Crystal JD, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D. Hohmann AG, et al. Nature. 2005 Jun 23;435(7045):1108-12. doi: 10.1038/nature03658. Nature. 2005. PMID: 15973410 Free article.

5

Cannabinoid mechanisms of pain suppression.

Walker JM, Hohmann AG. Walker JM, et al. Among authors: hohmann ag. Handb Exp Pharmacol. 2005;(168):509-54. doi: 10.1007/3-540-26573-2_17. Handb Exp Pharmacol. 2005. PMID: 16596786 Review.

6

Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis.

Gutierrez T, Farthing JN, Zvonok AM, Makriyannis A, Hohmann AG. Gutierrez T, et al. Among authors: hohmann ag. Br J Pharmacol. 2007 Jan;150(2):153-63. doi: 10.1038/sj.bjp.0706984. Epub 2006 Dec 11. Br J Pharmacol. 2007. PMID: 17160008 Free PMC article.

7

Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.

Rahn EJ, Makriyannis A, Hohmann AG. Rahn EJ, et al. Among authors: hohmann ag. Br J Pharmacol. 2007 Nov;152(5):765-77. doi: 10.1038/sj.bjp.0707333. Epub 2007 Jun 18. Br J Pharmacol. 2007. PMID: 17572696 Free PMC article.

8

Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain.

Guindon J, Hohmann AG. Guindon J, et al. Among authors: hohmann ag. Br J Pharmacol. 2008 Jan;153(2):319-34. doi: 10.1038/sj.bjp.0707531. Epub 2007 Nov 12. Br J Pharmacol. 2008. PMID: 17994113 Free PMC article. Review.

9

Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats.

Rahn EJ, Zvonok AM, Thakur GA, Khanolkar AD, Makriyannis A, Hohmann AG. Rahn EJ, et al. Among authors: hohmann ag. J Pharmacol Exp Ther. 2008 Nov;327(2):584-91. doi: 10.1124/jpet.108.141994. Epub 2008 Jul 29. J Pharmacol Exp Ther. 2008. PMID: 18664590 Free PMC article.

10

Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia.

Nyilas R, Gregg LC, Mackie K, Watanabe M, Zimmer A, Hohmann AG, Katona I. Nyilas R, et al. Among authors: hohmann ag. Eur J Neurosci. 2009 May;29(10):1964-78. doi: 10.1111/j.1460-9568.2009.06751.x. Epub 2009 May 9. Eur J Neurosci. 2009. PMID: 19453631 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page